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Telomeres play an important part in maintaining gen- telomeres are detected as DNA damage by the DNA
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http://www.genomeintegrity.com/content/4/1/2differentiated human cells lack telomerase, the enzyme
that synthesizes telomeric DNA, leading to telomere
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University, Uxbridge, Middlesex UB8 3PH, UKomic integrity and chromosomal stability. All eukaryotic
cells need to distinguish the natural chromosomal ends
from exogenously/endogenously induced DNA ends
resulting from DNA double strand breaks (DSBs) [1].
DNA DSBs in mammalian cells are processed by two
mechanisms - non-homologous end joining (NHEJ) and
homologous recombination (HR). It is now well
damage response mechanisms [3,4].
Telomere dysfunction can arise as a result of natural
telomere shortening (in the absence of telomerase), or
loss of function of the telomere protective protein com-
plex known as shelterin, or loss of function of some
DNA damage response proteins [3]. Telomere dysfunc-
tion as a result of telomere shortening leads to the
physiological process known as replicative senescence,
a p53-dependant antiproliferative mechanism. Dividing* Correspondence: hemad.yasaei@brunel.ac.uk; Predrag.slijepcevic@brunel.ac.uk
Division of Biosciences, Brunel Institute of Cancer Genetics andrequired for continued survival of mammalian cells.Background: Telomeres, the physical ends of chromosomes, play an important role in preserving genomic integrity.
This protection is supported by telomere binding proteins collectively known as the shelterin complex. The shelterin
complex protects chromosome ends by suppressing DNA damage response and acting as a regulator of telomere
length maintenance by telomerase, an enzyme that elongates telomeres. Telomere dysfunction manifests in different
forms including chromosomal end-to-end fusion, telomere shortening and p53-dependent apoptosis and/or
senescence. An important shelterin-associated protein with critical role in telomere protection in human and mouse
cells is the catalytic subunit of DNA-protein kinase (DNA-PKcs). DNA-PKcs deficiency in mouse cells results in elevated
levels of spontaneous telomeric fusion, a marker of telomere dysfunction, but does not cause telomere length
shortening. Similarly, inhibition of DNA-PKcs with chemical inhibitor, IC86621, prevents chromosomal end protection
through mechanism reminiscent of dominant-negative reduction in DNA-PKcs activity.
Results: We demonstrate here that the IC86621 mediated inhibition of DNA-PKcs in two mouse lymphoma cell lines
results not only in elevated frequencies of chromosome end-to-end fusions, but also accelerated telomere shortening
in the presence of telomerase. Furthermore, we observed increased levels of spontaneous telomeric fusions in Artemis
defective human primary fibroblasts in which DNA-PKcs was inhibited, but no significant changes in telomere length.
Conclusion: These results confirm that DNA-PKcs plays an active role in chromosome end protection in mouse and
human cells. Furthermore, it appears that DNA-PKcs is also involved in telomere length regulation, independently of
telomerase activity, in mouse lymphoma cells but not in human cells.
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Radiosensitivity
Introduction
Protection of genomic integrity is an essential function
documented that loss of telomeric function leads to
chromosomal end-to-end fusions and can trigger a cell
cycle arrest and apoptosis [2]. Therefore dysfunctionalAnalysis of telomere leng
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telomerase negative cells, they lose their protective
function and are subsequently detected by the DNA
damage response proteins as sites of DNA damage. The
presence of DNA damage at telomeres precludes fur-
ther cell division and results in p53-dependent cell
cycle arrest. Alternatively, telomere dysfunction can re-
sult from pathological mutations in genes encoding
(i) components of telomerase, (ii) components of the
shelterin complex and (iii) some DNA damage response
genes including those involved in NHEJ [5,6].
DNA-PKcs and Ku86 are key components of the NHEJ
pathway and have been demonstrated to interact directly
with telomeres in mammalian cells. Mice deficient for ei-
ther of these proteins have increased frequencies of telo-
mere end-to-end fusions without significant loss of
telomeric DNA [7,8] indicating that telomere dysfunction
can be independent of telomere length. Moreover, double
knock-out mice deficient in DNA-PKcs and telomerase
show accelerated telomere shortening, suggesting a func-
tional interaction between telomerase and DNA-PKcs in
maintenance of telomere length [8,9]. Another NHEJ pro-
tein shown to be involved in telomere maintenance is Ar-
temis [10]. Artemis is phosphorylated by DNA-PK
complex (DNA-PKcs and Ku70/Ku80) in response to
DNA-DSB and the activated endonuclease function of Ar-
temis is thought to be critical in 3’-overhang processing in
the NHEJ [11]. A range of DNA damage response proteins
involved in other DNA repair, damage signalling and
checkpoint pathways have been shown to associate, albeit
transiently, with shelterin and telomeres with documented
telomere dysfunction phenotypes [5].
The activity of DNA-PKcs can be inhibited using syn-
thetic chemical inhibitors such as 4-(morpholinyl)-4H-
naphthol[1,2-b]pyran-4-one (NU7026) or 1-(2-Hydroxy-4-
morpholin-4-yl-phenyl)ethanone (IC86621) [12]. IC86621
has been reported to affect catalytic subunit of DNA-PK
with increases in telomere end-to-end fusions [1].
In this study we set out to examine the effect of DNA-
PKcs inhibition on telomere maintenance and telomere
length regulation in two mouse lymphoma cell lines: the
parental radio-resistant L5178Y-R cell line (also known
as LY-R) and its subtype, the radiosensitive L5178Y-S cell
line (also known as LY-S) [13]. Moreover, we set out to
further elucidate the link between DNA-PKcs and Arte-
mis in telomere protection and telomere length regula-
tion in primary human fibroblasts.
Results and discussion
Inhibition of DNA-PKcs increases telomeric fusion and
dysfunction
LY-R and LY-S cells have been well characterized in
terms of DNA damage response capacities and telomere
maintenance. LY-R cells show normal sensitivity toionizing radiation (IR) and have telomeres typical of
mouse cells i.e. 40–50 kb [13,14]. In contrast, LY-S cells
show IR sensitivity [15] and have much shorter telomeres
which are in the region of ~ 7 kb. A recent study indicates
that this pair of cell lines may have different telomere
lengths in different laboratories [16]. The mechanisms of
increased IR sensitivity in LY-S cells are not known. It has
been suggested that this radiosensitivity is due to a defi-
ciency in the DSB repair machinery [17]. However, DNA-
PKcs and all components of NHEJ pathway known at the
time of investigation including Ku70/80 were functional in
both cell lines [13,18]. The only components of NHEJ not
examined in these cell lines are the more recently discov-
ered proteins XLF/Cernunnos and Artemis.
We started by analysing spontaneous chromosome ab-
normalities in the above cell lines using Telo-FISH. In
particular, we were interested in end-to-end chromo-
some fusions as these can result from telomere dysfunc-
tion. Since all mouse chromosomes are acrocentric
(Figure 1A) end-to-end chromosome fusions can be of
two types: Robertsonian (RB) fusions and classical telo-
meric fusions. RB fusions are characterized by the fusion
involving p-arm telomeres and the lack of telomeric
signals at the fusion point as shown in Figure 1B (white
arrows) [19]. Classical telomeric fusions are fusions
of either p-arm or q-arm telomeres that show clear
telomeric signals at fusion points as shown in Figure 1B
and C (red arrows) [19]. The mechanisms behind RB
fusion and telomeric fusion formation are different. It is
likely that RB fusion may arise as a result of telomere
shortening, whereas the classical telomeric fusions usu-
ally arise as a result of telomere dysfunction not involv-
ing changes in telomere length [19].
We observed a significant four-fold increase in fre-
quencies of RB fusions in LY-S cells relative to LY-R cells
(p < 0.0001) (Table 1). This increase could be the result
of LY-S cells having shorter telomeres (7Kb in LY-S and
49 Kb in LY-R) and higher levels of missing telomeric
signals [13].The analysis of telomeric fusions showed a
1.7-fold increase in LY-S cells in comparison to LY-R
cells (p < 0.0001). Mouse p-arm telomeres are signifi-
cantly shorter than q-arm telomeres [19] thus explaining
why the frequencies of RB fusions were greater than fre-
quencies of telomeric fusions in untreated LY-S cells
(Table 1). However, this does not hold true for LY-R cells
(Table 1) suggesting that mechanisms other than telo-
mere shortening may be involved. It is important to note
that the presence of critically short telomeres may affect
LY-S cells more dramatically than LY-R cells because of
their naturally short telomeres.
There was a 2.5-fold increase in the levels of spontan-
eous chromosome breaks in LY-S cells relative to LY-R
cells (Table 1 and Figure 1). The elevated levels of en-
dogenous chromosome breaks observed in the LY-S cell
A B C
Figure 1 Examples of chromosomal aberrations in LY-R and LY-S mouse cells. A| No evidence of chromosomal aberrations in untreated
mouse LY-R cells. Telomeric signals are in red with DNA counter stained in blue with DAPI. B| Elevated levels of Robertsonian fusion (white arrow)
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chinery in these cells as shown previously [17].
To inhibit DNA-PKcs activity we used a synthetic in-
hibitor IC86621. This is a highly specific inhibitor shown
to generate telomere dysfunction phenotypes in mam-
malian cells by directly affecting DNA-PKcs activity
[1,20]. Interestingly, inhibition of DNA-PKcs activity
caused significant increases in frequencies of RB fusions,
telomere fusions and chromosomal breaks and frag-
ments in both cell lines (Table 1). These increases in
levels of chromosome fusions in both LY-R and LY-S
treated cell lines are indicative of telomere dysfunction
resulting from inhibition of DNA-PKcs which is consist-
ent with a previously published study [1]. This adds fur-
ther support to the view that DNA-PKcs plays a role in
protecting telomere function.
Moreover, we observed significant increases in the levels
of telomeric fusions in the radiosensitive LY-S compared
to its parental radio-resistance LY-R following DNA-PKcs
induction (Table 1). The 1.5-fold increases in telomere fu-
and end-to-end telomeric fusions in DNA-PKcs inhibited mouse LY-S. C|
difference in telomeric signal strength between LY-S (weaker signal) and
mouse cell lines.sions in the LY-S cells indicates the fragility and sensitivity
of the telomeric-end protection in the LY-S cells compared
to the parental radio-resistance LY-R cells, and the
Table 1 Telo-FISH analysis of two mouse cell lines treated wit
Cell Line Metaphases Scored RB fu
LY-R
Untreated (DMSO) 213 0.037b ±
Treated (DNA-PKcsi) 201 0.088a ±
LY-S
Untreated (DMSO) 189 0.159b ±
Treated (DNA-PKcsi) 200 0.249a ±
Frequency of Robertsonian fusion, end-to-end telomeric fusions and DNA-DSB/fragm
cell lines. The inhibition was induced for 24 -hour period before metaphase prepara
metaphases were scored (except in LY-S untreated). S.D. was used as measure of di
a The difference in mean event/cell between untreated and treated cell lines are sig
b The difference in mean event/cell between untreated cell lines are significant (p <importance of DNA-PKcs in maintaining telomere-end
function. We next asked the question whether inhibition
of DNA-PKcs can affect telomere length in the
telomerase-positive LY-S and LY-R mouse lymphoma cell
lines.
Telomere length shortening following inhibition of DNA-
Pkcs in the LY-S and LY-R cell lines
To this end we analyzed telomere length using the Flow-
FISH method as described previously [21]. Our results
showed a ~ 5-fold difference in telomere length between
untreated LY-R and LY-S cells. Although, it has been
previously shown that telomeres in LY-R cells are ~ 6.9-
fold longer relative to their LY-S cell counterparts [13],
the smaller difference observed here may be explained
by the natural variation in telomere length in these two
cell lines. For example, Cabuy et al. (2004) found that
average telomere length in the LY-R cell line can vary
between 40-60% in the same population of cells cultured
for more than 20 population doublings. This natural
ilar observation in DNA-PKcs inhibited treated mouse LY-R. Note the
-R (stronger) suggesting differences in telomeric length of the twofluctuation in telomere length may explain why we ob-
served only a 5-fold difference (Figure 2) as opposed to
the previously published 6.9-fold difference [21].
h inhibitor of DNA-PKcs
Frequency (event/cell)
sion Telomeric Fusions Breaks/Fragments
0.012 0.075b ± 0.021 0.056
0.048 0.279a ± 0.011 0.277
0.025 0.126b ± 0.003 0.140
0.046 0.410a ± 0.027 0.212
ents were recorded from two independent experiments in the LY-R and LY-S
tion. DMSO was used as control treatment. In each experiment at least 100
spersion from the mean.
nificant (p < 0.05).
0.0001).
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this caused a reduction in the average telomere length
by 27% and 21% in LY-S and LY-R cell lines respectively
when compared to their untreated counterparts follow-
ing a 24 hour treatment with IC86621 (Figure 2). The
percentage difference in telomere fluorescence intensity
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Figure 2 Flow-FISH analysis of telomere length of mouse cell
lines following inhibition of DNA-PKcs activity. A reduction in TFI
unit where observed when both mouse cell lines were treated with
DNA-PKcs inhibitor. The difference between the percentage
reduction between the treated and untreated were statistically
significant (p < 0.0001). TFI unit were measured from at least 1000
cells in G0/G1 phase of cell cycle in each experiment from a total of
seven independent experiments. The error bars represent s.d.between treated and untreated cell lines was statistically
significant (p < 0.05) (Figure 2). This rapid significant re-
duction in telomere lengths in both cell lines could con-
tribute to increases in telomeric fusions &/or increased
DNA-DSBs and fragments observed above (Table 1).
This further underlies the importance of DNA-PKcs in
maintaining telomere function and also suggests that
DNA-PKcs may be involved in telomere length regulation
in mouse cells. Collectively, our data suggests that inhib-
ition of DNA-PKcs, through exposure of cells to IC86621,
causes not only loss of telomere function (Table 1,
Figure 1) but also rapid telomere shortening in mouse
lymphoma LY-R and LY-S cells (Figure 2). These cells
show a robust telomerase activity [13] suggesting that all
these changes occur independently of telomerase.
Inhibition of DNA-PKcs causes shorter telomere length in
human normal and Artemis defective primary cells
Artemis is a protein involved in repair of DNA DSBs
through the NHEJ pathway and it is phosphorylated by
DNA-PKcs [11,22]. It has been demonstrated that Arte-
mis is required for repair of a subset radiation-induced
DNA DSB in an ATM-dependent manner [23] and that
defective Artemis patients show radiosensitivity to high
[23] and low [10] doses of IR. Artemis defective patientalso show immunodeficiency [24], a combined syndrome
known as RS (radio sensitive)-SCID. We have demon-
strated previously that cells from Artemis-defective pa-
tients exhibit mild telomere dysfunction, increased levels
of irreparable telomere damage as measured by the telo-
mere dysfunction induced foci (TIF) assay [10]. Simi-
larly, inhibition of DNA-PKcs via IC86621 or its knock-
down via RNAi in Artemis defective cells caused a
slower DNA damage repair kinetics at telomeres
suggesting that both proteins are needed for the stable
maintenance of telomere function in human cells [10].
However, we have not analysed telomere length and fre-
quencies of telomeric fusions in our previous study.
Here, we analysed frequencies of telomeric fusions and
telomere length after DNA-PKcs inhibition, via IC86621,
in two primary Artemis defective fibroblast cell lines. In-
hibition of DNA-PKcs resulted in a ~50% reduction of
DNA-PKcs protein activity as previously described [10].
Cytological analysis revealed a significant elevation in telo-
meric fusions in the two Artemis defective cell lines rela-
tive to the normal control cell line (p < 0.05) (Table 2).
The majority of telomeric fusions observed were of chro-
matid type consistent with the observed effect of DNA-
PKcs inhibition described in other studies (Bailey et al.
2004) (Figure 3C). Similarly, the frequency of chromo-
some breaks in all three cell lines was increased in the
treated samples in comparison to untreated counterparts
(Table 2). This is suggestive of the importance of DNA-
PKcs in the efficient repair of spontaneous DNA DSB and
genomic stability.
Next, we examined the effect of DNA-PKcs inhibition
on telomere length in the same cell lines. The treatment
of all three cell lines with the DNA-PKcs inhibitor for a
period of 24 hour caused a reduction in the in telomere
length (Figure 4, Table 3). However, the difference in
telomere length between untreated and treated cell lines
was not significant (p < 0.164 for GM08399, p < 0.265 for
CJ179) in contrast to a significant difference observed in
the mouse LY-R and LY-S cells. It is therefore possible
that DNA-PKcs could affect telomere length regulation
mechanisms in human and mouse cell lines differently.
In line with this possibility it has been suggested that the
regulation of DNA-PKcs activity in human cells may be
different from that in others species such as mouse [25].
However, longer incubation of the human cells with the
DNA-PKcs inhibitor may produce a more significant re-
duction in telomere lengths in the radio-sensitive cells.
The mechanism of telomere shortening in the DNA-
PKcs induced immortal mouse lymphoma cells is un-
known and needs to be further investigated. The future
experiments should attempt to address the following
questions; is telomere length shortening a progressive
phenomenon in the absence of DNA-PKcs in both
mouse and human cells or does it occur only for one/or
two cell cycles? How does telomerase in the mouse
lymphoma cells play a role in maintaining telomere
length following inhibition of DNA-PKcs? The observed
telomere length shortening in both human and mouse
cells following a partial reduction in DNA-PKcs activity
was indeed interesting and merits further investigation
as to the mechanisms of DNA-PKcs activity on telomere
length in radio-sensitive mouse and human cells.
Conclusion
Our results indicate that inhibition of DNA-PKcs activity
via IC86621 causes a rapid telomere shortening in both
mouse lymphoma cell lines, in spite of active telomerase.
Furthermore, we observed elevated frequencies of Rb and
telomeric fusions in the same cell lines suggesting that
DNA-PKcs inhibition affects both telomere length and
function. However, the effect of DNA-PKcs in Artemis
Table 2 Analysis of total telomeric fusions in the primary human fibroblast cells
Frequency (event/cell)
Cell Line Metaphase cells analyzed Total telomeric fusions Breaks/Fragments
GM08399 (WT)
Untreated (DMSO) 111 0.018 ± 0.015 0.000 ± 0.000
Treated (DNA-PKcsi) 150 0.087 ± 0.028 0.067 ± 0.007
CJ179 (Art)
Untreated (DMSO) 194 0.067 ± 0.026 0.015 ± 0.009
Treated (DNA-PKcsi) 182 0.203 ± 0.047 0.104 ± 0.005
F01-240 (Art)
Untreated (DMSO) 174 0.081 ± 0.026 0.017 ± 0.012
Treated (DNA-PKcsi) 140 0.136 ± 0.021 0.157 ± 0.062
Frequencies of break/fragments in two Artemis defective human primary cells and normal human primary counterpart induced with DNA-PKcs inhibitor from two
independent experiments are shown. Numbers indicated are mean ± s.d.
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quences in that telomere shortening was not significant
after treatment with IC86621. This potentially reflects dif-
ferences between mouse and human cells in terms of
DNA-PKcs function and consequently the role that DNA-
PKcs plays at telomeres.
Materials and methods
Cell culture conditions
Mouse lymphoma LY-R and LY-S were grown in suspension
in RPMI 1640 medium (Gibco/Invitrogen) supplemented
with 10% fetal calf serum (Gibco/Invitrogen) at 37°C in the
0.0
Untreated Treated
Figure 4 Flow-FISH analysis of telomere lengths in human
primary fibroblasts. TFI units measured from at least four
independent experiments (two for F01-240) with DMSO served as
untreated control and IC86621 as inhibitor of DNA-PKcs. Error bars
represent s.d. The difference in telomere length was not
statistically significant.atmosphere of 10% CO2. LY-R and LY-S cells were
subcultured 1:10 ratio every two to three days, preferably be-
fore the medium colour changed to yellow.
Human Artemis defective primary fibroblast cell lines
(CJ179 and F01/240) and normal human primary fibro-
blast cell line (GM08399) were grown in Dulbecco’s
modified Eagle medium (D-MEM) supplemented with
10% fetal calf serum at 37°C with 10% CO2 as previously
Table 3 Telomere length measurement in primary human
cells measured by Flow-FISH
Telomere length in (kb)
Untreated Treated % change
GM08399 (WT) 5.97 ± 4.25 4.42 ± 4.02 26
CJ179 (Art) 5.00 ± 3.82 3.94 ± 3.60 21
F01-240 (Art) 6.69 5.04 25
The TFI units (see Figure 4) were converted into kb using the standardized
formula (see material and methods). The decline in telomere length in DNA-
PKcs inhibited samples was observed following 24-hours of treatment. The TFI
were measured from at least four independent experiments (except from one
experiment for F01-240) before the mean TFI’s were converted into kb. Mean
Telomere length is shown ± s.d.reported [10]. Cells were subcultured 1:4 ratio every
three to four days depending on the confluency level.
Inhibition of DNA-PKcs
IC86621 (Sigma Aldrich, CAS # 404009-40-1) was used
at a final concentration of 200μM for 24 hours to inhibit
catalytic subunit activity of DNA-PK. It has been shown
previously [1,10,20] that incubation of mammalian cells
with IC86621 for a period of 24hrs generates telomere
dysfunction as a direct result of inhibition of DNA-PKcs
activity. Cells were then used to analyze levels of telo-
mere dysfunction and telomere length following disrup-
tion of DNA-PKcs activity.
Telo-FISH
Telomere dysfunction analysis were performed on
metaphase spread using telomere-fluorescence in situ
hybridization as described previously [10]. In brief, a
synthetic short oligonucleotide sequence specific to
consensus telomeric sequence (CCCTAA)3 labelled
with Cy3 PNA probe (Applied Biosystems) were hy-
bridized to metaphase spreads at 65°C for two minutes.
Prior to hybridization slides were washed in PBS, fixed
with formaldehyde and digested with pepsin. After
hybridization, slides were left in a humidified chamber
for two hours and washed in 70% formamide. DAPI
was added once slides were air dried and sealed with
coverslip. All metaphase spreads were scored using
Zeiss Axioplan2 microscope and images were captured
using a CCD camera mounted on the microscope and
captured and analyzed with MetaSystem image acquisi-
tion software (Image Associate). Over one hundred
metaphase spreads were scored from each cell line for
evidence of telomere fusion.
FLOW-FISH
In vitro measurement of telomere length can be performed
using quantitative-fluorescence in vitro hybridization (Q-
FISH) technique on metaphase spreads or using fluores-
cence activated cell sorting (FACS) machine to measure
fluorescently labelled telomere sequences in high-
throughput. A detailed method of this technique has been
described previously [21]. In brief, 5x105 mouse lymphoma
cells grown in suspension were collected, washed in PBS at
least once. Cell pellets were then hybridized in the
hybridization buffer containing 500μl of hybridization mix-
ture of 70 percent formamide, 20mM Tris–HCl pH 7.0, 1
percent BSA made in PBS, and 0.3μg/ml of Fluorescein
isothiocyanate (FITC) conjugated peptide nucleic acid
(PNA) probe (CCCTAA)3. The hybridization mixture was
heated to 80°C for ten minutes. Samples without telomeric
PNA probe were used as negative control to measure back-
ground fluorescence and were normalized against the posi-
tive control samples. All samples were kept in dark for two
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hybridization to remove excess unbound PNA probes.
Wash solutions contained 70 percent formamide, 10mM
Tris–HCl, 0.1 percent BSA in PBS and 0.1 percent Tween-
20. Samples were centrifuged at 3,000 rpm for five minutes
after each wash. Second washes were done again twice
using a 500μl solution containing PBS, 0.1 percent BSA and
0.1 percent Tween-20 and cells were centrifuged at
2000rpm for five minutes. A second incubation was done
with propidium iodide (PI) (Sigma) containing PBS, 0.1 per-
cent BSA, 10μg/ml of RNase A, and 0.1μg/ml of PI to
quantitatively assess the DNA content of cells. The samples
were incubated in the dark for 45 minutes to one hour at
4°C. The samples were kept on ice all the time prior to the
measurement with the FACS machine. FACS Coulter
EPICS XL (Beckman Coulter) was calibrated using flow-
check fluorospheres (Beckman Coulter) before each meas-
urement. The software was calibrated to measure the
FITC-tagged telomeric signal on the FL1 channel, and the
PI signal on FL3 channel. Cells were electronically gated for
the G0/G1 phase of cell cycles form the FL3 histogram win-
dow. The Telomeric fluorescence intensity (TFI) of cells in
the G0/G1 stage was recorded. TFI from the negative con-
trol cells was also measured and subtracted from the main
sample reading to remove the background reading. TFI
readings from a minimum of 5,000 cells and a maximum of
20,000 cells were recorded and TFI units were converted
into base pairs using the formula y = 4.13x + 2.56 (R2 = 1)
[13]. The accuracy of this formula was tested using LY-R
and LY-S mouse cell lines.
Statistical analysis
Student t-test was used to compare the mean of two
samples with confidence interval set at 95% and α = 0.05.
Standard error of mean (SEM) and Standard deviation
(SD) was used as measure of dispersion.
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